+D Messenger RNA Biogenesis KO
#
Prokaryotic Defense System - Aliivibrio fischeri MJ11
%
!
ACRISPR-Cas system
B Universal Cas proteins
B Type I CRISPR-Cas system
C Type I signiture cas proteins
C Subtype I-A factors
C Subtype I-B factors
C Subtype I-C factors
C Subtype I-D factors
C Subtype I-E factors
C Subtype I-F factors
D VFMJ11_1056 conserved hypothetical protein K19128 csy2; CRISPR-associated protein Csy2
D VFMJ11_1055 csy_2; crispr-associated protein, Csy3 family K19129 csy3; CRISPR-associated protein Csy3
D VFMJ11_1054 csy_1; crispr-associated protein, Csy4 family K19130 csy4; CRISPR-associated endonuclease Csy4 [EC:3.1.-.-]
C Subtype I-U factors
B Type II CRISPR-Cas system
C Type II signiture cas proteins
C Subtype II-A factors
C Subtype II-B factors
B Type III CRISPR-Cas system
C Type III signiture cas proteins
C Subtype III-A factors
C Subtype III-B factors
C Subtype III-U factors
#
ARestriction and modification system (R-M system)
B Type I R-M system
C VFMJ11_2141 type I restriction-modification system, R subunit K01153 hsdR; type I restriction enzyme, R subunit [EC:3.1.21.3]
C VFMJ11_B0055 type I site-specific deoxyribonuclease K01153 hsdR; type I restriction enzyme, R subunit [EC:3.1.21.3]
C VFMJ11_B0054 restriction modification system S subunit K01154 hsdS; type I restriction enzyme, S subunit [EC:3.1.21.3]
C VFMJ11_2142 restriction modification system DNA specificity domain protein K01154 hsdS; type I restriction enzyme, S subunit [EC:3.1.21.3]
C VFMJ11_2143 type I restriction-modification system, M subunit K03427 hsdM; type I restriction enzyme M protein [EC:2.1.1.72]
C VFMJ11_B0053 type I restriction-modification system, M subunit K03427 hsdM; type I restriction enzyme M protein [EC:2.1.1.72]
B Type II R-M system
C Restriction endonucleases
C DNA methyltransferases
D VFMJ11_2401 retron EC67 DNA adenine methylase K06223 dam; DNA adenine methylase [EC:2.1.1.72]
B Type III R-M system
B Type IV R-M system
C VFMJ11_A0755 restriction endonuclease family K07448 mrr; restriction system protein
#
AToxin-antitoxin system (TA system)
B Type I TA system
C Hok-Sok
C SymE-SymR
C Ldr-Rdl
C TisB-IstR
C Ibs-Sib
C ShoB-OhsC
C RalR-RalA
B Type II TA system
C MazF-MazE
C ChpB-ChpS
C YhaV-PrlF
C RelE/StbE-RelB/StbD
D VFMJ11_A0688 toxin RelE K06218 relE; mRNA interferase RelE/StbE
D VFMJ11_A0687 stability protein StbD, putative K18923 stbD; antitoxin StbD
C YafQ-dinJ
C YoeB-YefM
C HipA-HipB
D VFMJ11_1565 protein HipA K07154 hipA; serine/threonine-protein kinase HipA [EC:2.7.11.1]
D VFMJ11_2144 HipA domain protein K07154 hipA; serine/threonine-protein kinase HipA [EC:2.7.11.1]
D VFMJ11_1564 HTH-type transcriptional regulator HipB K15773 hipB; HTH-type transcriptional regulator / antitoxin HipB
D VFMJ11_2145 putative transcriptional regulator, XRE family K15773 hipB; HTH-type transcriptional regulator / antitoxin HipB
C HicA-HicB
C YafO-YafN
C Hha-TomB
C PspC-PspB
D VFMJ11_A0351 pspC; phage shock protein C K03973 pspC; phage shock protein C
D VFMJ11_A0350 pspB; phage shock protein B K03970 pspB; phage shock protein B
C CcdB-CcdA
D VFMJ11_A0651 CcdB K19163 ccdB; toxin CcdB
D VFMJ11_A0650 CcdB antidote CcdA K19164 ccdA; antitoxin CcdA
C ParE-ParD
D VFMJ11_A0880 toxin of toxin-antitoxin stability system K19092 parE1_3_4; toxin ParE1/3/4
C Doc-Phd
C HigB-HigA
D VFMJ11_A0657 plasmid maintenance system killer protein K07334 higB-1; toxin HigB-1
D VFMJ11_A0656 higA; addiction module antidote protein, HigA family K21498 higA-1; antitoxin HigA-1
C MqsR-MqsA
C VapC-VapB
C PezT-PezA
C YobL-YobK
C YokI-YokJ
C YqcG-YqcF
C YxiD-YxxD
C FitB-FitA
C BC_0920-BC_0921
C Type II TA system related factors
D VFMJ11_A1008 conserved hypothetical protein K19334 tabA; biofilm protein TabA
D VFMJ11_2309 ftsZ; cell division protein FtsZ K03531 ftsZ; cell division protein FtsZ
D VFMJ11_0363 Rod shape-determining protein MreB K03569 mreB; rod shape-determining protein MreB and related proteins
D VFMJ11_2338 parC; DNA topoisomerase IV, A subunit K02621 parC; topoisomerase IV subunit A [EC:5.6.2.2]
D VFMJ11_2339 parE; DNA topoisomerase IV, B subunit K02622 parE; topoisomerase IV subunit B [EC:5.6.2.2]
D VFMJ11_2020 gltX; glutamyl-tRNA synthetase K01885 EARS; glutamyl-tRNA synthetase [EC:6.1.1.17]
B Type III TA system
C AbiQ system
B Type IV TA system
C YeeV-YeeU
C CptA-CptB
D VFMJ11_2201 protein VV1_1557 K09159 cptB; antitoxin CptB
B Type V TA system
C GhoT-GhoS
#
ADNA phosphothiolation system
B Sulfur modification proteins
C VFMJ11_0631 iscS; cysteine desulfurase IscS K04487 iscS; cysteine desulfurase [EC:2.8.1.7]
C VFMJ11_B0020 putative DGQHR domain protein K19169 dndB; DNA sulfur modification protein DndB
C VFMJ11_A0171 dndB; DNA sulfur modification protein DndB K19169 dndB; DNA sulfur modification protein DndB
C VFMJ11_A0170 dndC; putative sulfurtransferase DndC K19170 dndC; DNA sulfur modification protein DndC
C VFMJ11_A0169 dndD; DNA sulfur modification protein DndD K19171 dndD; DNA sulfur modification protein DndD
C VFMJ11_A0168 dndE; DNA sulfur modification protein DndE K19172 dndE; DNA sulfur modification protein DndE
B DNA phosphorothioation-dependent restriction proteins
C VFMJ11_A0163 dnd system-associated protein 3 K19173 dptF; DNA phosphorothioation-dependent restriction protein DptF
C VFMJ11_A0164 dnd system-associated protein 1 K19174 dptG; DNA phosphorothioation-dependent restriction protein DptG
C VFMJ11_A0165 dnd system-associated protein 2 K19175 dptH; DNA phosphorothioation-dependent restriction protein DptH
!
#
#[ BRITE | KEGG2 | KEGG ]
#Last updated: November 7, 2023